• 1
    Grinspoon L, Bakalar JB. Marihuana as medicine. A plea for reconsideration. JAMA 1995; 273: 18756.
  • 2
    De Petrocellis L, Cascio MG, Di Marzo V. The endocannabinoid system: a general view and latest additions. Br J Pharmacol 2004; 141: 76574.
  • 3
    Howlett AC, Barth F, Bonner TI et al. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161202.
  • 4
    Wright K, Rooney N, Feeney M et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 2005; 129: 43753.
  • 5
    Van Sickle MD, Duncan M, Kingsley PJ et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 32932.
  • 6
    Coutts AA, Pertwee RG. Evidence that cannabinoid- induced inhibition of electrically evoked contractions of the myenteric plexus- longitudinal muscle preparation of guinea-pig small intestine can be modulated by Ca2+ and cAMP. Can J Physiol Pharmacol 1998; 76: 3406.
  • 7
    Pertwee RG, Fernando SR, Nash JE, Coutts AA. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br J Pharmacol 1996; 118: 2199205.
  • 8
    Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Eur J Pharmacol 1999; 384: 3742.
  • 9
    Buckley NE, Hansson S, Harta G, Mezey E. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 1998; 82: 113149.
  • 10
    Storr M, Gaffal E, Saur D, Schusdziarra V, Allescher HD. Influence of cannabinoids on neurotransmission in rat gastric fundus. Can J Physiol Pharmacol 2002; 80: 6776.
  • 11
    Coutts AA, Irving AJ, Mackie K, Pertwee RG, Anavi-Goffer S. Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 2002; 448: 41022.
  • 12
    Kulkarni-Narla A, Brown DR. Opioid, cannabinoid and vanilloid receptor localisation on porcine cultured myenteric neurons. Neurosci Lett 2001; 308: 1536.
  • 13
    Casu MA, Porcella A, Ruiu S et al. Differential Distribution of functional cannabinoid CB1 receptors in the mouse gastrointestinal tract. Eur J Pharmacol 2003; 459: 97105.
  • 14
    Izzo AA, Fezza F, Capasso R et al. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 2001; 134: 56370.
  • 15
    Izzo AA, Mascolo N, Borrelli F, Capasso F. Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors. Br J Pharmacol 1998; 124: 13638.
  • 16
    Pinto L, Capasso R, Di Carlo G, Izzo AA. Endocannabinoids and the gut. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 33341.
  • 17
    Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut 2001; 48: 85967.
  • 18
    Ross RA, Brockie HC, Stevenson LA et al. Agonist-inverse agonist characterisation at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 1999; 126: 66572.
  • 19
    Marsicano G, Wotjak CT, Azad SC et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2001; 418: 5304.
  • 20
    Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A 1999; 96: 57805.
  • 21
    Pol O, Sanchez B, Puig MM. Peripheral effects of opioids in a model of intestinal inflammation in mice. Pharmacology 1996; 53: 34050.
  • 22
    Pol O, Ferrer I, Puig MM. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice. J Pharmacol Exp Ther 1994; 270: 38691.
  • 23
    Allescher HD, Storr M, Brechmann C, Hahn A, Schusdziarra V. Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum. Neuropeptides 2000; 34: 628.
  • 24
    Yüce B, Sibaev A, Haaken A et al. ORL-1 receptor mediates the action of nociceptin on ascending myenteric reflex pathways in rats. Gastroenterology 2007; doi: 10.1053/j.gastro.2007.05.016.
  • 25
    Ward SM, Dalziel HH, Thornbury KD, Westfall DP, Sanders KM. Nonadrenergic, noncholinergic inhibition and rebound excitation in canine colon depend on nitric oxide. Am J Physiol 1992; 262: G23743.
  • 26
    Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001; 22: 56572.
  • 27
    Heinemann A, Shahbazian A, Holzer P. Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways. Neuropharmacology 1999; 38: 128997.
  • 28
    Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut 2001; 48: 85967.
  • 29
    Calignano A, La Rana G, Mikriyanis A, Lin SA, Beltramo M, Piomelli D. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur J Pharmacol 1997; 340: R78.
  • 30
    Izzo AA, Mascolo N, Capasso F. The gastrointestinal pharmacology of cannabinoids. Curr Opin Pharmacol 2001; 1: 597603.
  • 31
    Capasso R, Matias I, Lutz B et al. Fatty Acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 2005; 129: 94151.
  • 32
    Carai MA, Colombo G, Gessa GL, Yalamanchili R, Basavarajppa BS, Hungund BL. Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice. Br J Pharmacol 2006; 148: 104350.
  • 33
    Izzo AA, Pinto L, Borrelli F, Capasso R, Mascolo N, Capasso F. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. Br J Pharmacol 2000; 129: 162732.
  • 34
    Izzo AA, Mascolo N, Tonini M, Capasso F. Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum. Br J Pharmacol 2000; 129: 98490.
  • 35
    Mancinelli R, Fabrizi A, Del Monaco S et al. Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse. Life Sci 2001; 69: 10111.
  • 36
    Mang CF, Erbelding D, Kilbinger H. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br J Pharmacol 2001; 134: 1617.
  • 37
    Lopez-Redondo F, Lees GM, Pertwee RG. Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurons of the guinea-pig ileum. Br J Pharmacol 1997; 122: 3304.
  • 38
    Ward SM, Burns AJ, Torihashi S, Sanders KM. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. J Physiol 1994; 480: 917.Pt 1
  • 39
    Der-Silaphet T, Malysz J, Hagel S, Larry AA, Huizinga JD. Interstitial cells of cajal direct normal propulsive contractile activity in the mouse small intestine. Gastroenterology 1998; 114: 72436.
  • 40
    Storr M, Sibaev A, Marsicano G et al. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. Am J Physiol Gastrointest Liver Physiol 2004; 286: G1107.